Four public health master’s students at the University of Montana are working on projects that tackle some of the largest health issues facing the state and region. The students recently earned the regional Student Leaders in Public Health Award from the Rocky Mountain Public Health Training Center in the Colorado School of Public Health. The award provides $3,500 to each project.
Montana State nursing college collaborating with Billings Clinic to expand representation and access in clinical trials
The new, three-year project aims at improving access throughout Montana to often life-saving treatments available through clinical trials. Funded with nearly $750,000 from biotechnology company Genentech through a grant aimed at advancing equitable access to health care, the project seeks to optimize portions of Billings Clinic’s electronic health record systems for clinical trials and engage underserved communities to let more people in the state receive clinical trial care.
FDA advisers support efficacy and safety of GSK’s RSV vaccine with more confidence than Pfizer rival
FDA advisers endorsed the safety and efficacy of GSK’s respiratory syncytial virus (RSV) vaccine in older adults, setting up a final mad dash with Pfizer as both companies eye the regulatory finish line with their promising new vaccines.
Montana State to host free workshop for biotech entrepreneurs March 6
MSU will host a free one-day workshop for biotechnology entrepreneurs and others interested in business ventures involving the life-sciences. The event will present practical information about starting a company, securing intellectual property, fundraising and licensing technology. The event is co-sponsored by the Montana Bioscience Alliance and the Montana Innovation Partnership.
Unique funding opportunity available for early career researchers related to conditions that co-occur with Down Syndrome
Awards will be offered by the National Institutes of Health and will be linked to grants currently held by the Institute of Translational Health Services and are open to: (1) students enrolled in doctoral programs at institutions of higher education in Washington, Wyoming, Alaska, Montana, and Idaho meeting T32/TL1 eligibility criteria, who can request 2 to 3 years of support for stipend and tuition, and (2) early career faculty and postdoctoral investigators meeting KL2 eligibility criteria, who can request support for 3 years of protected research time including salary and other support.
Gaize announces the launch of their real-time impairment screening device for cannabis and other drugs
Gaize, Inc. has announced the launch of their impairment screening solution for cannabis and other drugs. The product is a first-of-its-kind fully automated, non-invasive and portable eye movement test. It’s an objective way to detect the involuntary eye movement changes associated with impairment. Gaize recently completed the world’s largest cannabis impairment clinical trial, which validated the effectiveness of the product.
Make way to show kindness — Frederic Scheer, Alercell CEO
Frederic has been fighting cancer since 2017, when it was finally discovered, but it was not too early. He claims that as an entrepreneur he endured a series of health issues, but that these inspired him to launch Alercell, a company dedicated to the early detection of cancer. His new mission in life is to reform cancer detection practices at Alercell so that patients can avoid grueling treatment if the disease is detected at an early stage.
Alercell Launches Website Dedicated to New Cancer Detection Tests
Alercell has launched a new website—Lena Diagnostics, www.lenadx.com—dedicated to proprietary tests focused on early detection of cancer and leukemia.
Experimental NIH Sudan Virus Vaccine Protects Macaques
A National Institutes of Health research group with extensive experience studying ebolavirus countermeasures has successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine.
Golden Helix — Enabling Precision Medicine
For over 20 years Golden Helix has been a software company that innovates genetic analysis software for next-generation sequencing (NGS) – and, believing that its customers and employees are at the heart of its success, it has built a glowing reputation as the industry leader in its field.